- Date: Oct 12 - 15, 2026
- Location: San Diego, California
Solidifying ADCs as Standard of Care Therapies by De-Risking Differentiated Payload MoAs Beyond Topo1, Elevating ADCs to Deliver Wider Impact in the Clinical Landscape & Adapting Manufacturing Efficiency for Novel & Cost-Effective ADCs
With groundbreaking readouts and approvals into first-line metastatic indications and early-stage, neoadjuvant and adjuvant settings, the new era of ADCs are starting to enter the clinic and attract dealmaking attention, unlocking the next wave of differentiated ADCs to redefine the future standard of care in oncology and beyond.
Returning as the largest and definitive ADC congress, the 17th World ADC San Diego is THE one-stop bioconjugate shop bringing together the global ADC community for an unparalleled amalgamation of case studies, development trends and impactful networking opportunities to forge ADC innovation into differentiated, early-line patient outcomes.
With 7 streams of end-to-end ADC content across Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process & Analytical Development, and Manufacturing & Supply Stream, all the ADC innovation will be in the spotlight for an unmissable week of data and insights to de‑risk future ADC development and push ADCs into earlier‑line oncology treatments.
Uniting 1,300 industry senior enthusiasts from oncology pharma, ADC biotech's, innovative start-ups, leading service providers and academic and physician KOLs, World ADC San Diego is where the industry comes to move forward.
If you are serious about ADCs, this is where you need to be.
View Event Website